Collegium Pharmaceutical Inc. | Key People and Executives
Michael Thomas Heffernan
Chairman
Joseph J. Ciaffoni
President, Chief Executive Officer & Director
Gwen A. Melincoff
Independent Director
John Gordon Freund
Independent Director
John A. Fallon
Independent Director
Gino Santini
Lead Independent Director
Theodore R. Schroeder
Independent Director
Garen G. Bohlin
Independent Director
David J. Hirsch
Independent Director
Michael Thomas Heffernan
Chairman
Joseph J. Ciaffoni
President, Chief Executive Officer & Director
Paul Brannelly
CFO, Principal Accounting Officer & Executive VP
Alison Fleming
Chief Technology Officer
Scott Dreyer
Chief Commercial Officer & Executive VP
Michael DeGeorge
Vice President-Medical Affairs
Scott Sudduth
Vice President-Supply Chain
Steven D. Passik
VP-Scientific Affairs, Education & Policy
Douglas R. Carlson
Vice President-Corporate Development
Said Saim
Vice President-Pharmaceutical Development
Arun Padmanabhan
Vice President-Marketing
Raimonds Dzelme
Vice President-Marketing
Jack Maroney
Vice President-Sales
Alex Dasalla
Press Contact
Shirley R. Kuhlmann
Secretary, Executive VP & General Counsel
John Weet
VP-Regulatory Affairs & Quality Assurance
Gwen A. Melincoff
Independent Director
John Gordon Freund
Independent Director
John A. Fallon
Independent Director
Gino Santini
Lead Independent Director
Theodore R. Schroeder
Independent Director
Garen G. Bohlin
Independent Director
David J. Hirsch
Independent Director
| Address |
100 Technology Center Drive
Stoughton Massachusetts 02072
United States
|
|
Employees
|
- |
| Website |
http://www.collegiumpharma.com |
| Updated |
07/08/2019 |
| Collegium Pharmaceutical, Inc. engages in the development and commercialization of next-generation, abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER, and ONSOLIS. Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. |
